NO993066L - Ny behandling for leddinflammasjon - Google Patents
Ny behandling for leddinflammasjonInfo
- Publication number
- NO993066L NO993066L NO993066A NO993066A NO993066L NO 993066 L NO993066 L NO 993066L NO 993066 A NO993066 A NO 993066A NO 993066 A NO993066 A NO 993066A NO 993066 L NO993066 L NO 993066L
- Authority
- NO
- Norway
- Prior art keywords
- joint inflammation
- new treatment
- treatment
- subtance
- glucocorticoid
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title abstract 2
- 208000018937 joint inflammation Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9604751A SE9604751D0 (sv) | 1996-12-20 | 1996-12-20 | New therapy |
| PCT/SE1997/002124 WO1998027987A1 (en) | 1996-12-20 | 1997-12-16 | New treatment for joint inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993066D0 NO993066D0 (no) | 1999-06-21 |
| NO993066L true NO993066L (no) | 1999-06-21 |
Family
ID=20405107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993066A NO993066L (no) | 1996-12-20 | 1999-06-21 | Ny behandling for leddinflammasjon |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6432937B1 (cs) |
| EP (1) | EP0957922A1 (cs) |
| JP (1) | JP2001507024A (cs) |
| KR (1) | KR20000069594A (cs) |
| AU (1) | AU5502598A (cs) |
| BR (1) | BR9713975A (cs) |
| CA (1) | CA2274769A1 (cs) |
| CZ (1) | CZ219399A3 (cs) |
| EE (1) | EE9900258A (cs) |
| HU (1) | HUP0000397A3 (cs) |
| ID (1) | ID21763A (cs) |
| IL (1) | IL130485A0 (cs) |
| IS (1) | IS5056A (cs) |
| NO (1) | NO993066L (cs) |
| NZ (1) | NZ336025A (cs) |
| PL (1) | PL334012A1 (cs) |
| SE (1) | SE9604751D0 (cs) |
| SK (1) | SK82699A3 (cs) |
| TR (1) | TR199901413T2 (cs) |
| WO (1) | WO1998027987A1 (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007322033B2 (en) | 2006-11-20 | 2013-07-11 | President And Fellows Of Harvard College | Methods, compositions, and kits for treating pain and pruritis |
| US20100160351A1 (en) * | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| WO2010071865A1 (en) | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| US20120172429A1 (en) | 2009-07-10 | 2012-07-05 | Woolf Clifford J | Permanently charged sodium and calcium channel blockers as anti- inflammatory agents |
| WO2011032175A1 (en) | 2009-09-14 | 2011-03-17 | Nuon Therapeutics, Inc. | Combination formulations of tranilast and allopurinol and methods related thereto |
| MX348961B (es) | 2011-02-18 | 2017-07-04 | Asana Biosciences Llc | Compuestos de aminoindano y su uso en el tratamiento del dolor. |
| JP6495654B2 (ja) | 2011-10-24 | 2019-04-03 | アサナ バイオサイエンシズ，リミティド ライアビリティ カンパニー | シクロヘキシルアミン類 |
| US9944637B2 (en) | 2013-12-16 | 2018-04-17 | Asana Biosciences, Llc | P2X3 and/or P2X2/3 compounds and methods |
| RU2018107695A (ru) | 2015-08-03 | 2019-09-05 | Президент Энд Феллоуз Оф Гарвард Колледж | Заряженные блокаторы ионных каналов и способы их применения |
| JP2016193937A (ja) * | 2016-08-09 | 2016-11-17 | 株式会社エヌ・エル・エー | 関節痛緩和組成物および機能性食品、並びに発酵ショウガ及びその製造方法 |
| WO2018064135A1 (en) | 2016-09-30 | 2018-04-05 | Asana Biosciences, Llc | P2x3 and/or p2x2/3 compounds and methods |
| US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| JP7630439B2 (ja) | 2019-03-11 | 2025-02-17 | ノシオン セラピューティクス，インコーポレイテッド | エステル置換イオンチャンネル遮断薬および使用方法 |
| EP3937929A4 (en) | 2019-03-11 | 2022-12-28 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
| JP7692834B2 (ja) | 2019-03-11 | 2025-06-16 | ノシオン セラピューティクス，インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
| CA3155568A1 (en) | 2019-11-06 | 2021-05-14 | Bridget Mccarthy Cole | Charged ion channel blockers and methods for use |
| WO2021091585A1 (en) | 2019-11-06 | 2021-05-14 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| IL295950A (en) | 2020-03-11 | 2022-10-01 | Nocion Therapeutics Inc | Charged ion channel blockers and methods of use |
| US12162851B2 (en) | 2020-03-11 | 2024-12-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8903914D0 (sv) | 1989-11-22 | 1989-11-22 | Draco Ab | Oral composition for the treatment of inflammatory bowel diseases |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| CA2140660A1 (en) * | 1993-06-13 | 1994-12-22 | Uwe R. Juergens | Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
-
1996
- 1996-12-20 SE SE9604751A patent/SE9604751D0/xx unknown
-
1997
- 1997-12-16 NZ NZ336025A patent/NZ336025A/en unknown
- 1997-12-16 CA CA002274769A patent/CA2274769A1/en not_active Abandoned
- 1997-12-16 WO PCT/SE1997/002124 patent/WO1998027987A1/en not_active Application Discontinuation
- 1997-12-16 BR BR9713975-0A patent/BR9713975A/pt not_active IP Right Cessation
- 1997-12-16 KR KR1019997005573A patent/KR20000069594A/ko not_active Withdrawn
- 1997-12-16 EE EEP199900258A patent/EE9900258A/xx unknown
- 1997-12-16 PL PL97334012A patent/PL334012A1/xx unknown
- 1997-12-16 AU AU55025/98A patent/AU5502598A/en not_active Abandoned
- 1997-12-16 ID IDW990480A patent/ID21763A/id unknown
- 1997-12-16 HU HU0000397A patent/HUP0000397A3/hu unknown
- 1997-12-16 US US09/011,623 patent/US6432937B1/en not_active Expired - Fee Related
- 1997-12-16 EP EP97951366A patent/EP0957922A1/en not_active Withdrawn
- 1997-12-16 SK SK826-99A patent/SK82699A3/sk unknown
- 1997-12-16 IL IL13048597A patent/IL130485A0/xx unknown
- 1997-12-16 CZ CZ992193A patent/CZ219399A3/cs unknown
- 1997-12-16 JP JP52868498A patent/JP2001507024A/ja active Pending
- 1997-12-16 TR TR1999/01413T patent/TR199901413T2/xx unknown
-
1999
- 1999-05-27 IS IS5056A patent/IS5056A/is unknown
- 1999-06-21 NO NO993066A patent/NO993066L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU5502598A (en) | 1998-07-17 |
| EE9900258A (et) | 1999-12-15 |
| PL334012A1 (en) | 2000-01-31 |
| IS5056A (is) | 1999-05-27 |
| HUP0000397A3 (en) | 2001-01-29 |
| TR199901413T2 (xx) | 1999-08-23 |
| IL130485A0 (en) | 2000-06-01 |
| NZ336025A (en) | 2001-02-23 |
| CZ219399A3 (cs) | 1999-09-15 |
| NO993066D0 (no) | 1999-06-21 |
| EP0957922A1 (en) | 1999-11-24 |
| SE9604751D0 (sv) | 1996-12-20 |
| KR20000069594A (ko) | 2000-11-25 |
| CA2274769A1 (en) | 1998-07-02 |
| ID21763A (id) | 1999-07-22 |
| JP2001507024A (ja) | 2001-05-29 |
| SK82699A3 (en) | 2000-02-14 |
| US6432937B1 (en) | 2002-08-13 |
| HUP0000397A2 (hu) | 2000-10-28 |
| BR9713975A (pt) | 2000-04-11 |
| WO1998027987A1 (en) | 1998-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993066L (no) | Ny behandling for leddinflammasjon | |
| AU6675198A (en) | Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use | |
| AR021981A1 (es) | Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero | |
| FI964249A0 (fi) | Muovipäällysteinen, amoksisilliinia ja klavulanaattia käsittävä tabletti | |
| CO4290346A1 (es) | Formas de dosificacion de liberacion controlada de azitromicina | |
| ES2128761T3 (es) | Formulacion de tirilazad con cosolvente para administracion parenteral. | |
| MX9700538A (es) | Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares. | |
| EE05506B1 (et) | Ravimi manustamise vahend eriti progestiinide jastrogeenide manustamiseks | |
| DE69710065D1 (de) | Androsten-derivate | |
| ID23806A (id) | Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin | |
| NZ505073A (en) | Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases | |
| HUP9903931A2 (hu) | Indolopirrolokarbazolok citotoxikus aminocukor- és más rokon jellegű cukorszármazékai | |
| EE9600172A (et) | Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
| NO20004419L (no) | Ny anvendelse | |
| DE69932510D1 (de) | Vaskularisierungsinhibitoren | |
| DK1033990T3 (da) | 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud | |
| NO963749L (no) | Transdermalt system i form av et plaster med et tamoxifen-derivat | |
| RS49701B (sr) | Vodene suspenzije za nazalnu primenu | |
| RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
| EE04954B1 (et) | Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm | |
| TR200002248T2 (tr) | Yeni dihidroksiheksanoik asit türevleri | |
| ES2147163A1 (es) | Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion. | |
| DK1189595T3 (da) | Ophthalmiske sammensætninger i form af vandige geler | |
| ATE28188T1 (de) | Antikonvulsive mittel. | |
| IT1291895B1 (it) | Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |